Analysts Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Tar

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among brokerages […]

Related Keywords

Stifel Nicolaus , Georgew Lemaitre , Davidb Roberts , Nasdaq , Conestoga Capital Advisors , Lemaitre Vascular , Congress Asset Management Co , Lemaitre Vascular Inc , Copeland Capital Management , Barrington Research , Vanguard Group Inc , Keycorp , Lemaitre Vascular Company Profile , Securities Exchange Commission , Get Free Report , Maitre Vascular , Director David , Exchange Commission , Capital Advisors , Capital Management , Congress Asset Management , Asset Management , Get Free , Lemaitre Vascular Daily ,